Enhancing Recovery From Sepsis: A Review.
#Overgrowth mods without codee plus
Hydrocortisone plus Fludrocortisone for Adults with Septic Shock. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. a sad final fizzle to a roller-coaster party. Efficacy and safety of recombinant human activated protein C for severe sepsis. Angiotensin II for the Treatment of Vasodilatory Shock. Efficacy and safety of dopamine versus norepinephrine in the management of septic shock. Comparison of dopamine and norepinephrine in the treatment of shock. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. 109(3):40-5 quiz 46.ĭellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM. Nelson DP, Lemaster TH, Plost GN, Zahner ML. A prospective, multicenter derivation of a biomarker panel to assess risk of organ dysfunction, shock, and death in emergency department patients with suspected sepsis. Shapiro NI, Trzeciak S, Hollander JE, et al. Early determinants of death due to multiple organ failure after noncardiac surgery in high-risk patients.
A multicenter prospective study in intensive care units. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. 26 Suppl 1:S64-74.īrun-Buisson C, Doyon F, Carlet J, Dellamonica P, Gouin F, Lepoutre A, et al. The epidemiology of the systemic inflammatory response. Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study. A prospective, observational registry of patients with severe sepsis: the Canadian Sepsis Treatment and Response Registry. Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. Epidemiology and economic evaluation of severe sepsis in France: age, severity, infection site, and place of acquisition (community, hospital, or intensive care unit) as determinants of workload and cost. 369(9):840-51.Īdrie C, Alberti C, Chaix-Couturier C, Azoulay E, De Lassence A, Cohen Y. New players in the sepsis-protective activated protein C pathway. Acute renal failure in critically ill patients: a multinational, multicenter study.
Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S. Alterations of mitochondrial function in sepsis and critical illness. Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag A, et al. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. American College of Chest Physicians/Society of Critical Care Medicine. The ACCP/SCCM Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Multiple organ failure in sepsis: prognosis and role of systemic inflammatory response. Multiple, progressive, or sequential systems failure.
0 kommentar(er)
